NTRK2 and depressive disorder: The signaling pathway comprising brain-derived neurotrophic factor (BDNF) and its specific receptor tropomyosin-receptor-kinase B (TrkB) plays a key role in the pathophysiology of depression and in the antidepressant functions of antidepressants [10–18].